In today's pharmaceutical market, conventional wisdom is being thrown into the air, according to Alan Clark, managing director of Lilly UK and vice president of Lilly Industries, speaking at a recent New Orleans, USA, conference organized by Dendrite International, a proprietary computer systems, service and support group to pharmaceutical companies for improving sales performance.
At one time, the pharmaceutical companies shaped the environment, he said; now, the customer is shaping the environment, and changing customer groups are destabilizing the pharmaceutical industry and shattering old orthodoxies.
In the past, he added, it was possible to talk to a leader, and the results of that meeting would cascade into a centrally-driven policy. However, in today's environment, Mr Clark told delegates, it is much less likely that a national, homogeneous marketing strategy will maximize market share. Therefore, central management has become a problem.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze